Quimigen Portugal > PDGFRB Antibody
PDGFRB Antibody
Referência OAEE00645
Tamanho : 100tests(T100)
Marca : Aviva Systems Biology
Bulk
Order
Order
Aviva's
Satisfaction
Guarantee
Satisfaction
Guarantee
Contact Us:
- Toll Free: 888-880-0001
- Phone: 858-552-6979
- Email: info@avivasysbio.com
Shipping Info:
- : Antibody & Protein in US
- + /Kit in US
- Contact us for international orders.
| Datasheets/Manuals | Printable datasheet for PDGFRB Antibody |
|---|
| Predicted Species Reactivity | Human |
|---|---|
| Product Format | Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide |
| Clonality | Monoclonal |
| Clone | 18A2 |
| Isotype | IgG1 |
| Host | Mouse |
| Conjugation | R-PE |
| Application | FC |
| Reconstitution and Storage | 2°C to 8°C |
| Immunogen | CD140b-transfected NIH 3T3 cells |
| Purification | Purified by size-exclusion chromatography |
| Concentration | 20 ul / test |
| Specificity | The monoclonal antibody 18A2 recognizes CD140b / PDGF-RB, the 180-190 kDa beta chain of platelet-derived growth factor receptor, which is widely expressed on a variety of mesenchymal-derived cells and plays pro-proliferative roles. |
| Formulation | PE |
| Storage Buffer | The reagent is provided in phosphate buffered saline (PBS) containing 15 mM sodium azide and 0.2% (w/v) high-grade protease free Bovine Serum Albumin (BSA) as a stabilizing agent. |
| Reference | Fekete N, Rojewski MT, Fürst D, Kreja L, Ignatius A, Dausend J, Schrezenmeier H: GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS One. 2012;7(8):e43255. doi: 10.1371/journal.pone.0043255 Faraone D, Aguzzi MS, Toietta G, Facchiano AM, Facchiano F, Magenta A, Martelli F, Truffa S, Cesareo E, Ribatti D, Capogrossi MC, Facchiano A: Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo. Neoplasia. 2009 Aug;11(8):732-42. Schmahl J, Rizzolo K, Soriano P: The PDGF signaling pathway controls multiple steroid-producing lineages. Genes Dev. 2008 Dec 1;22(23):3255-67. French WJ, Creemers EE, Tallquist MD: Platelet-derived growth factor receptors direct vascular development independent of vascular smooth muscle cell function. Mol Cell Biol. 2008 Sep;28(18):5646-57. Andrae J, Gallini R, Betsholtz C: Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008 May 15;22(10):1276-312. |
|---|---|
| Gene Symbol | PDGFRB |
| Gene Full Name | platelet derived growth factor receptor beta |
| Alias Symbols | Activated tyrosine kinase PDGFRB, beta-type platelet-derived growth factor receptor, CD140 antigen-like family member B, CD140B, IBGC4, IMF1, JTK12, KOGS, NDEL1-PDGFRB, PDGF-R-beta, PDGFR, PDGFR-1, PDGFR-beta, PDGFR1, PENTT, platelet-derived growth factor receptor 1, platelet-derived growth factor receptor beta, platelet-derived growth factor receptor, beta polypeptide. |
| NCBI Gene Id | 5159 |
| Protein Name | receptor protein-tyrosine kinase |
| Uniprot ID | P09619 |
| Protein Accession # | NP_002600.1 |
| Nucleotide Accession # | NM_002609.3 |
Protein interactions
| Name | # of Products | |
|---|---|---|
| ADRBK1 | 77 | |
| ARAF | 77 | |
| BAG1 | 37 | |
| COPA | 37 | |
| COPB1 | 39 | |
| EIF2AK2 | 125 | |
| GAB1 | 76 | |
| GRB10 | 74 | |
| GRB14 | 63 | |
| GRB7 | 109 | |
| KRTAP4-12 | 129 | 5 |
| NCK1 | 212 | |
| NCK2 | 111 | |
| P | 47 | |
| PDAP1 | 16 | |
| PDCD6IP | 81 | |
| PDGFB | 59 | |
| PDGFD | 5 | |
| PIK3C2B | 15 | |
| PIK3R2 | 182 | |
| PIK3R3 | 78 | |
| PRDX2 | 9 | |
| PTK2 | 335 | |
| PTPN1 | 49 | |
| PTPN11 | 309 | |
| PTPN2 | 55 | |
| PTPRJ | 24 | |
| S1PR1 | 33 | |
| SHC1 | 492 | |
| SLC9A3R1 | 127 | |
| SNX1 | 29 | |
| SNX2 | 42 | |
| SNX4 | 38 | |
| SOCS1 | 152 | |
| SRC | 773 | |
| STAT1 | 201 | |
| STAT5A | 180 | |
| STAT5B | 184 | |
| SYNGAP1 | 35 | |
| TYK2 | 111 | |
| UBC | 7030 |
Biological pathways
| Name | # of Products |
|---|---|
| Aorta morphogenesis | 17 |
| Cardiac myofibril assembly | 24 |
| Cell migration involved in coronary angiogenesis | 6 |
| Cell migration involved in vasculogenesis | 6 |
| Metanephric glomerular capillary formation | 26 |
| Metanephric glomerular mesangial cell proliferation involved in metanephros development | 7 |
| Peptidyl-tyrosine phosphorylation | 165 |
| Phosphatidylinositol metabolic process | 21 |
| Phosphatidylinositol-mediated signaling | 285 |
| Positive regulation of calcium ion import | 15 |
| Positive regulation of chemotaxis | 23 |
| Positive regulation of DNA biosynthetic process | 23 |
| Positive regulation of ERK1 and ERK2 cascade | 194 |
| Positive regulation of MAP kinase activity | 147 |
| Positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 19 |
| Positive regulation of mitosis | 179 |
| Positive regulation of phosphatidylinositol 3-kinase activity | 98 |
| Positive regulation of phosphatidylinositol 3-kinase cascade | 210 |
| Positive regulation of phospholipase C activity | 65 |
| Positive regulation of phosphoprotein phosphatase activity | 10 |
| Positive regulation of reactive oxygen species metabolic process | 55 |
| Positive regulation of smooth muscle cell migration | 54 |
| Positive regulation of smooth muscle cell proliferation | 123 |
| Protein autophosphorylation | 356 |
| Regulation of actin cytoskeleton organization | 31 |
| Retina vasculature development in camera-type eye | 20 |
| Smooth muscle cell chemotaxis | 5 |
Biological process
| Name | # of Products |
|---|---|
| Adrenal gland development | 31 |
| Aorta morphogenesis | 8 |
| Cardiac myofibril assembly | 10 |
| Cell chemotaxis | 24 |
| Cell migration | 113 |
| Cell migration involved in coronary angiogenesis | 3 |
| Cell migration involved in vasculogenesis | 4 |
| Hemopoiesis | 78 |
| In utero embryonic development | 199 |
| Kidney development | 92 |
| Metanephric glomerular capillary formation | 5 |
| Metanephric glomerular mesangial cell proliferation involved in metanephros development | 4 |
| Multicellular organismal development | 896 |
| Nitrogen compound metabolic process | 16 |
| Peptidyl-tyrosine phosphorylation | 72 |
| Phosphatidylinositol metabolic process | 15 |
| Phosphatidylinositol-mediated signaling | 74 |
| Platelet-derived growth factor receptor signaling pathway | 27 |
| Platelet-derived growth factor receptor-beta signaling pathway | 3 |
| Positive regulation of calcium ion import | 9 |
| Positive regulation of cell migration | 150 |
| Positive regulation of cell proliferation | 483 |
| Positive regulation of chemotaxis | 14 |
| Positive regulation of DNA biosynthetic process | 8 |
| Positive regulation of ERK1 and ERK2 cascade | 103 |
| Positive regulation of MAP kinase activity | 56 |
| Positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 7 |
| Positive regulation of mitosis | 50 |
| Positive regulation of phosphatidylinositol 3-kinase activity | 39 |
| Positive regulation of phosphatidylinositol 3-kinase cascade | 60 |
| Positive regulation of phospholipase C activity | 10 |
| Positive regulation of phosphoprotein phosphatase activity | 5 |
| Positive regulation of reactive oxygen species metabolic process | 31 |
| Positive regulation of smooth muscle cell migration | 26 |
| Positive regulation of smooth muscle cell proliferation | 67 |
| Protein autophosphorylation | 150 |
| Regulation of actin cytoskeleton organization | 24 |
| Regulation of peptidyl-tyrosine phosphorylation | 17 |
| Retina vasculature development in camera-type eye | 5 |
| Signal transduction | 1058 |
| Skeletal system morphogenesis | 30 |
| Smooth muscle cell chemotaxis | 2 |
| Smooth muscle tissue development | 21 |
| Tissue homeostasis | 17 |
| Vascular endothelial growth factor receptor signaling pathway | 42 |
Cellular components
| Name | # of Products |
|---|---|
| Apical plasma membrane | 173 |
| Cytoplasm | 4549 |
| Cytoplasmic membrane-bounded vesicle | 93 |
| Integral to plasma membrane | 817 |
| Intrinsic to plasma membrane | 4 |
| Lysosomal lumen | 24 |
| Membrane | 2769 |
| Nucleus | 4914 |
| Plasma membrane | 2678 |
Protein function
| Name | # of Products |
|---|---|
| ATP binding | 2814 |
| Nucleotide binding | 3928 |
| Platelet activating factor receptor activity | 6 |
| Platelet-derived growth factor beta-receptor activity | 6 |
| Platelet-derived growth factor binding | 66 |
| Platelet-derived growth factor receptor binding | 96 |
| Platelet-derived growth factor-activated receptor activity | 6 |
| Protein binding | 12191 |
| Protein tyrosine kinase activity | 369 |
| Receptor activity | 3624 |
| Receptor binding | 932 |
| Signal transducer activity | 1270 |
| Vascular endothelial growth factor binding | 20 |
Diseases
| Name | # of Products |
|---|---|
| Proto-oncogene | 793 |
-
PDGFRB Antibody (OAAB04748)Catalog #: OAAB04748Application: IF,IHC-P,WBFormat: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. -
PDGFRB Antibody (OAED00016)Catalog #: OAED00016Clone: 42G12Application: Western blotFormat: Liquid. In PBS, pH 7.2, containing 0.09% sodium azide and 50% glycerol. -
PDGFR Beta Colorimetric Cell-Based ELISA Kit (OKAG00959)Catalog #: OKAG00959Application: ELISAKit Range: At least 5000 cells/wellFormat: 96-Well Microplate -
PDGFRB Antibody (Phospho-Tyr751) (OASG05750)Catalog #: OASG05750Application: ELISA, IF, IHC, WBFormat: Liquid. PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.



